Best Science Podcasts 2026

Everything Everywhere Daily

Daily

Gary Clark delivers a fascinating 10-minute history or science lesson every single day. Over 1,500 episodes and counting — the most consistent education podcast on the planet.

→ WHAT IT COVERS Three historically documented riots — the 1855 Toronto Circus Riot, the 1922 New York Straw Hat Riot, and the 1864 Leicester Balloon

Stuff You Should Know

3x/week

Josh and Chuck have been making curiosity fun since 2008. From black holes to bizarre laws — endlessly entertaining and surprisingly educational.

→ WHAT IT COVERS Josh Clark and Chuck Bryant explore the science behind fever dreams in this 2017 episode, breaking down how pyrogens trigger fevers,

TED Radio Hour

Weekly

TED talks woven into narrative journalism by NPR. Big ideas made human, one theme at a time.

→ WHAT IT COVERS TED Radio Hour explores three approaches to preserving human knowledge permanently: Brewster Kahle's Internet Archive has saved over

Huberman Lab

2x/week

Stanford neuroscientist Andrew Huberman turns peer-reviewed research into actionable protocols for sleep, focus, exercise, and stress.

→ WHAT IT COVERS Dr. Erich Jarvis, neurobiologist at Rockefeller University, explains how speech and language share brain circuits with movement pathw

Citeline Podcasts

Daily

Industry intelligence on clinical trials, regulatory trends, and pharma strategy from Citeline's expert analysts.

→ WHAT IT COVERS Generics Bulletin editors report from two February 2026 industry conferences — AAM's Access meeting in Miami and Medicines for Europe

Freakonomics Radio

Weekly

The hidden side of everything. Stephen Dubner uses economics to explain why the world works the way it does — always surprising, always rigorous.

→ WHAT IT COVERS Freakonomics Radio profiles Judy Faulkner, 82-year-old founder and CEO of Epic Systems, which holds electronic health records for ove

The Peter Attia Drive

Biweekly

Dr. Peter Attia goes deeper on longevity science than anyone else in media. Rigorous, evidence-based, and laser-focused on extending healthspan.

→ WHAT IT COVERS Peter Attia examines why prostate cancer deaths are rising despite available screening tools, presenting data showing current USPSTF

Beyond Biotech

Weekly

Labiotech.eu's official podcast — broad global coverage of biotech news, partnerships, and emerging therapies. Great for a European perspective on drug development.

→ WHAT IT COVERS Patrick Andre, CSO of Diagonal Therapeutics, explains how the company's clustering antibody platform targets the root cause of heredi

Lex Fridman Podcast

Biweekly

Marathon conversations with Nobel laureates, world leaders, and the sharpest minds in AI. Lex asks the questions no one else dares to.

→ WHAT IT COVERS Historian Lars Brownworth traces the Viking Age from the 793 Lindisfarne raid through three centuries of Norse expansion, covering lo

Biotech Bulls & Breakthroughs

Biweekly

Focused on small-cap and mid-cap biotech catalysts — phase 3 data readouts, FDA decisions, and the binary events that move stocks. Essential for biotech investors.

→ WHAT IT COVERS Biotech trader Chef Station and BioPharm Catalyst's John Galliano review mid-2026 catalysts across 15+ small-cap biotech stocks, cove

Moonshots with Peter Diamandis

2x/week

Peter Diamandis interviews innovators working on exponential technologies. Optimistic, ambitious, and focused on solutions over problems.

→ WHAT IT COVERS Peter Diamandis interviews Elon Musk at the Abundance Summit, covering recursive AI self-improvement timelines, Optimus 3 robot produ

The Biotech Startups Podcast

2x/week

Founders share the real stories of building biotech companies — from lab to Series A. Rare operational insight into life science startups.

→ WHAT IT COVERS Richard Yu, cofounder and CEO of Abalone Bio, traces his path from physics undergraduate at UC Berkeley in 1989 through structural bi

ZOE Science & Nutrition

2x/week

Tim Spector and the ZOE team break down nutrition science with real data. Personalized health backed by the largest nutrition study ever.

→ WHAT IT COVERS Professor Tim Spector breaks down carbohydrates into simple sugars, starches, and fibers, explaining why eliminating all carbs is mis

The Genius Life

2x/week

Max Lugavere covers brain health, nutrition, and cognitive performance with the latest research. Practical protocols for mental sharpness.

→ WHAT IT COVERS Dave Evans, cofounder of the Stanford Life Design Lab and coauthor of Designing Your Life , applies design thinking principles to me

Biotech Hangout

Weekly

Friday roundtable with Daphne Zohar, Brad Loncar, and rotating guests. Fast-paced weekly recap of biotech news, deals, and FDA actions — like a biotech happy hour with insiders.

→ WHAT IT COVERS Biotech Hangout Episode 180 covers the XBI reaching post-pandemic highs, Kilera's $625M IPO, Revolution Medicines' pancreatic cancer

Making Sense

Weekly

Sam Harris examines the biggest questions in philosophy, science, and ethics with clarity and intellectual honesty. Fearlessly tackles uncomfortable ideas.

→ WHAT IT COVERS Sam Harris analyzes the U.S. war against Iran's regime, evaluating the Trump administration's strategic failures and communication in

Radiolab

WNYC Studios

Weekly

WNYC's Radiolab uses investigative journalism and sound design to explore science, philosophy, and the human experience. Pioneered the genre.

→ WHAT IT COVERS Radiolab traces the New World screwworm — a flesh-eating fly parasite eradicated from North America using USDA entomologist Edward Ni

The Readout Loud

Weekly

STAT News' weekly biotech podcast — breaks down clinical trial results, FDA policy shifts, and industry deals. The newsroom perspective that biotech investors trust.

→ WHAT IT COVERS This episode covers three biotech stories: Vinay Prasad's second departure from the FDA and its impact on rare disease drug approvals

BioCentury This Week

Weekly

The gold standard for weekly biotech industry analysis. BioCentury's editorial team breaks down deals, clinical data, and regulatory moves with investor-grade rigor.

→ WHAT IT COVERS BioCentury This Week examines biotech capital markets momentum amid geopolitical uncertainty, Xenon Pharmaceuticals' phase three epil

Ologies

Weekly

Alie Ward interviews experts from every scientific field — volcanology, mycology, lepidopterology. Curiosity-driven, hilarious, and genuinely educational.

→ WHAT IT COVERS Double board-certified allergist and immunologist Dr. Zachary Rubin, author of the New York Times bestselling book All About Allergi

In Our Time

Weekly

Melvyn Bragg and guests explore 3,000 years of ideas in 45 minutes. BBC Radio 4's crown jewel — history, philosophy, and science at the highest level.

→ WHAT IT COVERS Three Assyriology scholars examine the Code of Hammurabi — a nearly 300-law basalt stele carved around 1750 BC by Babylonian king Ham

Science Vs

Weekly

Wendy Zukerman puts popular claims under the microscope. Entertaining, rigorous, and unafraid to challenge what everyone thinks they know.

→ WHAT IT COVERS Science Vs examines the rise of colorectal cancer in adults under 55, exploring why millennials face two to three times higher risk t

The Bio Report

Weekly

Award-winning biotech journalist Daniel Levine covers where biotechnology meets business, policy, and science. Concise, well-researched episodes for busy professionals.

→ WHAT IT COVERS Immuneering CEO Ben Zeskind explains how the company's informatics-driven "deep cyclic inhibition" approach to MEK inhibition deliver

The Proof

Weekly

Simon Hill examines nutrition claims through the lens of published research. Evidence over opinion — the most scientifically rigorous nutrition podcast.

→ WHAT IT COVERS Stanford professor Christopher Gardner, who served on the 2025 Dietary Guidelines Advisory Committee, and GAIN nutrition scientist Ty

Hidden Brain

Weekly

Shankar Vedantam uses science and storytelling to reveal the unconscious patterns that drive human behavior. NPR at its most fascinating.

→ WHAT IT COVERS Cornell psychologist Jonathan Rottenberg, who experienced four years of severe depression in his twenties, challenges the dominant "d

Sean Carroll's Mindscape

Weekly

Caltech physicist Sean Carroll explores the deepest questions in physics, philosophy, and consciousness. Intellectually expansive and generous.

→ WHAT IT COVERS Law professor Andrew Guthrie Ferguson explains how smartphones, smart home devices, cars, and wearables continuously generate data th

Business Of Biotech

Weekly

Ben Comer (Life Science Leader) interviews biotech CEOs on the operational realities of building a drug company — from fundraising to commercialization.

→ WHAT IT COVERS Marc Hedrick, CEO of Plus Therapeutics, details the development of Rhenium-186 radiotherapeutic Rayovik for CNS cancers including gli

The Happiness Lab

Weekly

Dr. Laurie Santos distills Yale's most popular course on happiness into actionable science. What actually makes humans happier — and what doesn't.

→ WHAT IT COVERS Psychologist Guy Winch and Chase for Business CEO Ben Walter present evidence-based strategies for preventing work stress from hijack

The Long Run with Luke Timmerman

Biweekly

Veteran biotech journalist Luke Timmerman goes deep with CEOs, VCs, and scientists. Thoughtful long-form interviews that reveal the people and strategies behind biotech companies.

→ WHAT IT COVERS Otello Stampacchia, founder of Omega Funds, outlines the structural and financial barriers holding back European biotech, where compa

Biotech 2050 Podcast

Biweekly

Forward-looking conversations on where biotech is headed — gene therapy, synthetic biology, and the next-gen platform technologies reshaping drug discovery.

→ WHAT IT COVERS Adial Pharmaceuticals CEO Cary Claiborne explains how AD04, a repurposed low-dose ondansetron, targets a specific genetic biomarker f

The Life Science Rundown

Biweekly

Quick daily briefings on the latest in drug development, clinical trials, and life science news. Built for biopharma professionals.

→ WHAT IT COVERS Cary Smithson of Leap Ahead Solutions outlines how life science companies must establish structured data governance frameworks to mee

Drug Story

Weekly

Deep dives into the stories behind breakthrough drugs — how they were discovered, developed, and brought to patients. Narrative-driven and accessible to non-specialists.

→ WHAT IT COVERS Tim Harford traces the rise of Lydia Pinkham's Vegetable Compound, a 20% alcohol herbal tonic marketed to women in the 1870s-1900s, e

The RTW Podcast

Monthly

Real-time commentary on biotech investing trends, clinical data readouts, and sector dynamics from an investment research perspective.

→ WHAT IT COVERS Rod Wong, founder and CIO of RTW Investments, traces biotech's evolution from the 2000 Human Genome Project through today's commercia

Found My Fitness

Monthly

Dr. Rhonda Patrick dives deep into the molecular mechanisms of nutrition, aging, and human performance. PhD-level science made actionable.

→ WHAT IT COVERS Dr. Charles Brenner, discoverer of nicotinamide riboside, explains NAD biology and its role in cellular energy, DNA repair, and infla

Pathfinders in Biopharma

Monthly

Biopharma leaders share how they navigated the path from discovery to commercialization. Hard-won lessons from drug development veterans.

→ WHAT IT COVERS RBC Capital Markets analyst Brian Abrams assesses biotech's 80% rally from April 2025 lows, evaluating whether sector momentum can pe